Christine Lindenboom | Investor Relations |
John Maraganore | Chief Executive Officer |
Tolga Tanguler | Chief Commercial Officer |
Akshay Vaishnaw | President of Research and Development |
Jeff Poulton | Chief Financial Officer |
Yvonne Greenstreet | President and Chief Operating Officer |
Gena Wang | Barclays |
Alethia Young | Cantor Fitzgerald |
Maury Raycroft | Jefferies |
Salveen Richter | Goldman Sachs |
Paul Matteis | Stifel |
Ritu Baral | Cowen |
Tazeen Ahmad | Bank of America |
Mani Foroohar | SVB Leerink |
Luca Issi | RBC |
Ladies and gentlemen, thank you for standing by. And welcome to the Alnylam Pharmaceuticals Q2 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I'd now like to turn the call over to your, Christine Lindenboom.